Tina Fanoe - Novozymes A/S Executive Vice President Agriculture & Bioenergy
| NVZMF Stock | USD 57.54 2.54 4.23% |
President
Ms. Tina Sejersgaard Fanoe was Executive Vice President, Agriculture Bioenergy at Novozymes AS since February 8, 2016. She is also Board Member of DLF AS. Previously, she was Vice President of Sales at the Company. She holds MS in Chemical Engineering from the Technical University of Denmark, as well as Bachelor of Arts degree in Philosophy and Education from Copenhagen University, Denmark. She started her career with the company in 1993 and has held various positions within RD, Marketing, Business Development and Sales. since 2016.
| Age | 54 |
| Tenure | 9 years |
| Phone | 45 44 46 00 00 |
| Web | https://www.novozymes.com |
Novozymes A/S Management Efficiency
The company has return on total asset (ROA) of 0.1062 % which means that it generated a profit of $0.1062 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.2789 %, meaning that it generated $0.2789 on every $100 dollars invested by stockholders. Novozymes A/S's management efficiency ratios could be used to measure how well Novozymes A/S manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | PRESIDENT Age | ||
| Andreas Opfermann | Linde plc Ordinary | 48 | |
| David Dennsteadt | RPM International | N/A | |
| Gordon Hyde | RPM International | 57 | |
| JeanMarc Royere | LAir Liquide SA | 58 | |
| David Sewell | Sherwin Williams Co | 51 | |
| Jonathan Reid | Sherwin Williams Co | 53 | |
| Amy Ericson | PPG Industries | 59 | |
| Wilbur Mok | Air Products and | 64 | |
| Fabienne Lecorvaisier | LAir Liquide SA | 61 | |
| Jill Wyant | Ecolab Inc | 49 | |
| Anne Roby | Linde plc Ordinary | 54 | |
| Peter Ippolito | Sherwin Williams Co | 61 | |
| Heidi Petz | Sherwin Williams Co | 50 | |
| Scott Kirkland | Ecolab Inc | 50 | |
| Mary Garceau | Sherwin Williams Co | 52 | |
| Michael Sullivan | RPM International | 58 | |
| William Spaulding | RPM International | N/A | |
| Darrell Brown | Ecolab Inc | 60 | |
| Timothy Mulhere | Ecolab Inc | 61 | |
| Pascal Vinet | LAir Liquide SA | 61 | |
| Anup Sharma | LyondellBasell Industries NV | 45 | |
Management Performance
| Return On Equity | 0.28 | |||
| Return On Asset | 0.11 |
Novozymes AS B Leadership Team
Elected by the shareholders, the Novozymes A/S's board of directors comprises two types of representatives: Novozymes A/S inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Novozymes. The board's role is to monitor Novozymes A/S's management team and ensure that shareholders' interests are well served. Novozymes A/S's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Novozymes A/S's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Pedro Fernandes, Head America | ||
| Tobias Bjorklund, Head of Investor Relations | ||
| Ester Baiget, Pres CEO | ||
| Tue Micheelsen, VP Marketing | ||
| Sebastian Sderberg, VP Acquisitions | ||
| Tina Fanoe, Executive Vice President Agriculture & Bioenergy | ||
| Graziela Malucelli, Supply Operations | ||
| Anders Lund, Executive Vice President Household Care & Technical Industries | ||
| Morten Rasmussen, Sustainability People | ||
| MSc MSc, Ex CFO |
Novozymes Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right pink sheet is not an easy task. Is Novozymes A/S a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.28 | |||
| Return On Asset | 0.11 | |||
| Profit Margin | 0.21 % | |||
| Operating Margin | 0.26 % | |||
| Current Valuation | 14.47 B | |||
| Shares Outstanding | 222.86 M | |||
| Shares Owned By Insiders | 8.04 % | |||
| Shares Owned By Institutions | 42.30 % | |||
| Price To Earning | 33.38 X | |||
| Price To Book | 6.19 X |
Currently Active Assets on Macroaxis
Other Information on Investing in Novozymes Pink Sheet
Novozymes A/S financial ratios help investors to determine whether Novozymes Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Novozymes with respect to the benefits of owning Novozymes A/S security.